SCHEMBL29825901

SCHEMBL29825901

CC(=O)N[C@H]1[C@H](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]3[C@H](O)[C@@H](O)C(O)O[C@@H]3CO)[C@@H]2O)O[C@H](CO[C@]2(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@@H]([C@H](O)[C@H](O)CO)O2)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.66

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ SIGLEC7 Q9Y286 6/20 0.64
▸ SELP P16109 2/20 0.63
▸ SELL P14151 2/20 0.63
▸ MAG P20916 6/20 0.60
▸ SELE P16581 4/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31716789 1.00 SIGLEC7 (0.64) SIGLEC7SELPSELLMAGSELE
SCHEMBL31717454 1.00 SIGLEC7 (0.64) SIGLEC7SELPSELLMAGSELE
SCHEMBL31717358 0.97 SELP (0.65) SIGLEC7SELPSELLMAGSELE
SCHEMBL31716409 0.97 SELP (0.65) SIGLEC7SELPSELLMAGSELE
SCHEMBL31702215 0.96 SELP (0.63) SIGLEC7SELPSELLMAGSELE
SCHEMBL30649633 0.96 SELP (0.65) SIGLEC7SELPSELLMAGSELE
SCHEMBL30185417 0.95 SELL (0.65) SIGLEC7SELPSELLMAGSELE
SCHEMBL31700317 0.95 SIGLEC7 (0.69) SIGLEC7SELPSELLMAGSELE
SCHEMBL30894716 0.95 SIGLEC7 (0.69) SIGLEC7SELPSELLMAGSELE
SCHEMBL31717039 0.95 SIGLEC7 (0.69) SIGLEC7SELPSELLMAGSELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024130119-A9 SYNBIOTIC COMPOSITIONS FOR SHORT CHAIN FATTY ACID PRODUCTION PROLACTA BIOSCIENCE, INC. (US) 2025-03-20 — — WO claimed
WO-2024130119-A2 SYNBIOTIC COMPOSITIONS FOR SHORT CHAIN FATTY ACID PRODUCTION PROLACTA BIOSCIENCE, INC. (US) 2024-06-20 — — WO claimed
EP-4281181-A1 TOPICAL HUMAN MILK FORMULATIONS Prolacta Bioscience, Inc. (US) 2023-11-29 — — EP disclosed
EP-4034143-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY AND IMMUNE DISEASES Prolacta Bioscience, Inc. (US) 2022-08-03 — — EP disclosed
WO-2022159705-A1 TOPICAL HUMAN MILK FORMULATIONS PROLACTA BIOSCIENCE, INC. (US) 2022-07-28 — — WO disclosed
Send feedback